GL1X · GenesisL1 explorer

Ligand · VU1

VU1 · 4-[(piperidin-1-yl)methyl]benzoic acid

VU1, 4-[(piperidin-1-yl)methyl]benzoic acid (C13 H17 N O2, 219.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands…

Component
VU1
Formula
C13 H17 N O2
Class
ligand
Structures
2
PDB entries
1

Binding sites

VU1 in 2 structures; the first of them:

  • 7JZQ · CFTR Associated Ligand (CAL) PDZ domain bound to peptidomimetic LyCALPMB · VU1 C101 · binds ASP287, HIS288, GLU289, GLY290, GLN314, LYS9
  • 7JZQ · Cftr associated ligand (cal) PDZ domain bound to peptidomimetic lycalpmb · VU1 C101 · binds ASP287, HIS288, GLU289, GLY290, GLN314, LYS9

Residues it binds most

ASP 2, GLN 2, GLU 2, GLY 2, HIS 2, LYS 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.